VEGFR2 and Src Kinase Inhibitors Suppress Andes Virus-Induced Endothelial Cell Permeability
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
VEGFR2 and Src Kinase Inhibitors Suppress Andes Virus-Induced Endothelial Cell Permeability
Authors
Keywords
-
Journal
JOURNAL OF VIROLOGY
Volume 85, Issue 5, Pages 2296-2303
Publisher
American Society for Microbiology
Online
2010-12-23
DOI
10.1128/jvi.02319-10
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SRC: A Century of Science Brought to the Clinic
- (2015) Alexey Aleshin et al. NEOPLASIA
- Vascular endothelial growth factor-targeted therapy in metastatic renal cell carcinoma
- (2010) Brian I. Rini CANCER
- Phase 1 pharmacokinetic and drug-interaction study of dasatinib in patients with advanced solid tumors
- (2010) Faye M. Johnson et al. CANCER
- Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
- (2010) Anna I. Markowska et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Pathogenic Hantaviruses Direct the Adherence of Quiescent Platelets to Infected Endothelial Cells
- (2010) I. N. Gavrilovskaya et al. JOURNAL OF VIROLOGY
- Andes Virus Disrupts the Endothelial Cell Barrier by Induction of Vascular Endothelial Growth Factor and Downregulation of VE-Cadherin
- (2010) P. Shrivastava-Ranjan et al. JOURNAL OF VIROLOGY
- Andes Virus Regulation of Cellular MicroRNAs Contributes to Hantavirus-Induced Endothelial Cell Permeability
- (2010) T. Pepini et al. JOURNAL OF VIROLOGY
- Pathogenic Hantaviruses Andes Virus and Hantaan Virus Induce Adherens Junction Disassembly by Directing Vascular Endothelial Cadherin Internalization in Human Endothelial Cells
- (2010) E. Gorbunova et al. JOURNAL OF VIROLOGY
- Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)
- (2010) F. M. Iwamoto et al. NEURO-ONCOLOGY
- Interventions Against West Nile Virus, Rift Valley Fever Virus, and Crimean-Congo Hemorrhagic Fever Virus: Where Are We?
- (2010) Jeroen Kortekaas et al. VECTOR-BORNE AND ZOONOTIC DISEASES
- Endogenous endothelial cell signaling systems maintain vascular stability
- (2009) Nyall R. London et al. ANGIOGENESIS
- Dengue Hemorrhage in a Mouse Model
- (2009) Betty A. Wu-Hsieh et al. Annals of the New York Academy of Sciences
- Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties
- (2009) C Hegedűs et al. BRITISH JOURNAL OF PHARMACOLOGY
- Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion
- (2009) Kimmo Porkka et al. CANCER
- Pathogen translocation across the blood-brain barrier
- (2009) Lucia Pulzova et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer–Soft Tissue and Bone Sarcoma Group (EORTC Study 62043)
- (2009) Stefan Sleijfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Andes Virus Recognition of Human and Syrian Hamster 3 Integrins Is Determined by an L33P Substitution in the PSI Domain
- (2009) V. S. Matthys et al. JOURNAL OF VIROLOGY
- Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors
- (2009) Andrew R Reynolds et al. NATURE MEDICINE
- Hantavirus regulation of endothelial cell functions
- (2009) Irina Gavrilovskaya et al. THROMBOSIS AND HAEMOSTASIS
- Reversal of West Nile virus-induced blood–brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor
- (2009) Saguna Verma et al. VIROLOGY
- Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea
- (2008) Janice M. Rusnak et al. ANTIVIRAL RESEARCH
- Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis
- (2008) M. P. Kim et al. CELL AND TISSUE RESEARCH
- Angiopoietin-1 Prevents VEGF-Induced Endothelial Permeability by Sequestering Src through mDia
- (2008) Julie Gavard et al. DEVELOPMENTAL CELL
- Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma
- (2008) Guru Sonpavde et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Breaking the VE-cadherin bonds
- (2008) Julie Gavard FEBS LETTERS
- Vascular endothelium: the battlefield of dengue viruses
- (2008) Atanu Basu et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
- The role of adherens junctions and VE-cadherin in the control of vascular permeability
- (2008) E. Dejana et al. JOURNAL OF CELL SCIENCE
- Hantaviruses Direct Endothelial Cell Permeability by Sensitizing Cells to the Vascular Permeability Factor VEGF, while Angiopoietin 1 and Sphingosine 1-Phosphate Inhibit Hantavirus-Directed Permeability
- (2008) I. N. Gavrilovskaya et al. JOURNAL OF VIROLOGY
- SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
- (2008) A. Vultur et al. MOLECULAR CANCER THERAPEUTICS
- Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability
- (2008) Christopher A Jones et al. NATURE MEDICINE
- Treatment of hantavirus pulmonary syndrome
- (2007) Colleen B. Jonsson et al. ANTIVIRAL RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started